More accurate breast cancer test could be available in two years

A study led by University College Dublin (UCD), the Royal College of Surgeons in Ireland (RCSI) and OncoMark Limited found that the OncoMasTR test offers greater accuracy than other currently available tests or risk assessment tools.

A new breast cancer test, offering a more accurate prediction of the risk of the disease recurring, could become available to patients in the next two years.

A study led by University College Dublin (UCD), the Royal College of Surgeons in Ireland (RCSI) and OncoMark Limited found that the OncoMasTR test offers greater accuracy than other currently available tests or risk assessment tools.